238 related articles for article (PubMed ID: 18343923)
1. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.
Goldstein OG; Hajiaghamohseni LM; Amria S; Sundaram K; Reddy SV; Haque A
Cancer Immunol Immunother; 2008 Oct; 57(10):1461-70. PubMed ID: 18343923
[TBL] [Abstract][Full Text] [Related]
2. High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma.
Buetow KH; Meador LR; Menon H; Lu YK; Brill J; Cui H; Roe DJ; DiCaudo DJ; Hastings KT
J Immunol; 2019 Nov; 203(10):2577-2587. PubMed ID: 31591149
[TBL] [Abstract][Full Text] [Related]
3. GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.
Rausch MP; Meador LR; Metzger TC; Li H; Qiu S; Anderson MS; Hastings KT
J Immunol; 2020 Jun; 204(11):2877-2886. PubMed ID: 32269095
[TBL] [Abstract][Full Text] [Related]
4. GILT Expression in Human Melanoma Cells Enhances Generation of Antigenic Peptides for HLA Class II-Mediated Immune Recognition.
Hathaway-Schrader JD; Norton D; Hastings K; Doonan BP; Fritz ST; Bethard JR; Blum JS; Haque A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162988
[TBL] [Abstract][Full Text] [Related]
5. Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma.
Nguyen J; Bernert R; In K; Kang P; Sebastiao N; Hu C; Hastings KT
Melanoma Res; 2016 Apr; 26(2):125-37. PubMed ID: 26930048
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis.
Zhao D; Hajiaghamohseni LM; Liu X; Szulc ZM; Bai A; Bielawska A; Norris JS; Reddy SV; Hannun YA; Haque A
Cytokine; 2020 Nov; 135():155219. PubMed ID: 32738771
[TBL] [Abstract][Full Text] [Related]
7. Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing.
Hastings KT; Lackman RL; Cresswell P
J Immunol; 2006 Dec; 177(12):8569-77. PubMed ID: 17142755
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent.
O'Donnell PW; Haque A; Klemsz MJ; Kaplan MH; Blum JS
J Immunol; 2004 Jul; 173(2):731-5. PubMed ID: 15240658
[TBL] [Abstract][Full Text] [Related]
9. Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO.
Kremer AN; van der Meijden ED; Honders MW; Goeman JJ; Wiertz EJ; Falkenburg JH; Griffioen M
Blood; 2012 Oct; 120(16):3246-55. PubMed ID: 22889757
[TBL] [Abstract][Full Text] [Related]
10. Diverse cellular and organismal functions of the lysosomal thiol reductase GILT.
Rausch MP; Hastings KT
Mol Immunol; 2015 Dec; 68(2 Pt A):124-8. PubMed ID: 26116226
[TBL] [Abstract][Full Text] [Related]
11. GILT modulates CD4+ T-cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1.
Rausch MP; Hastings KT
J Invest Dermatol; 2012 Jan; 132(1):154-62. PubMed ID: 21833020
[TBL] [Abstract][Full Text] [Related]
12. GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.
Rausch MP; Irvine KR; Antony PA; Restifo NP; Cresswell P; Hastings KT
J Immunol; 2010 Sep; 185(5):2828-35. PubMed ID: 20668223
[TBL] [Abstract][Full Text] [Related]
13. Peptide Modification Diminishes HLA Class II-restricted CD4
Doonan BP; Amria S; Bethard JR; Banik NL; Hathaway-Schrader JD; Haque A
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499557
[TBL] [Abstract][Full Text] [Related]
14. GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity.
Phipps-Yonas H; Semik V; Hastings KT
Eur J Immunol; 2013 Jan; 43(1):65-74. PubMed ID: 23012103
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells.
Costantino CM; Ploegh HL; Hafler DA
J Immunol; 2009 Jul; 183(2):945-52. PubMed ID: 19553543
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol.
Radwan FF; Zhang L; Hossain A; Doonan BP; God JM; Haque A
Leuk Lymphoma; 2012 Feb; 53(2):305-14. PubMed ID: 21854084
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.
Tsuji T; Matsuzaki J; Caballero OL; Jungbluth AA; Ritter G; Odunsi K; Old LJ; Gnjatic S
J Immunol; 2012 Apr; 188(8):3851-8. PubMed ID: 22427632
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.
Zhao D; Amria S; Hossain A; Sundaram K; Komlosi P; Nagarkatti M; Haque A
Cell Immunol; 2011; 271(2):392-400. PubMed ID: 21903207
[TBL] [Abstract][Full Text] [Related]
19. MHC class II-restricted presentation of the major house dust mite allergen Der p 1 Is GILT-dependent: implications for allergic asthma.
West LC; Grotzke JE; Cresswell P
PLoS One; 2013; 8(1):e51343. PubMed ID: 23326313
[TBL] [Abstract][Full Text] [Related]
20. Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma.
Norton DL; Haque A
J Oncol; 2009; 2009():142959. PubMed ID: 20016802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
